BESPOKE LIFE LIMITED
Company number 15595324 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
BESPOKE LIFE LIMITED - Analysis Report
Company Number: 15595324
Analysis Date: 2025-07-29 12:48 UTC
Financial Health Assessment for BESPOKE LIFE LIMITED
1. Financial Health Score: B
Explanation:
Bespoke Life Limited demonstrates a sound start with positive net current assets and shareholders’ funds, reflecting a stable liquidity position and initial equity base after its first year of operations. The absence of debt beyond modest current liabilities and a healthy cash balance are encouraging signs. However, as a newly incorporated company with limited financial history and no reported turnover or profit and loss data available, the overall assessment is cautiously positive but not yet at the level of an established, robust business.
2. Key Vital Signs
| Metric | Value (£) | Interpretation |
|---|---|---|
| Cash at Bank | 46,177 | Healthy cash flow for a start-up; sufficient liquidity to cover short-term obligations. |
| Current Liabilities | 20,340 | Low liabilities indicating manageable short-term debts. |
| Net Current Assets | 25,837 | Positive working capital, indicating liquidity buffer and operational solvency. |
| Shareholders’ Funds | 25,837 | Indicates initial equity investment plus any retained earnings; solid foundation. |
| Turnover & Profit & Loss | Not disclosed | Lack of income and profitability data limits deeper profitability analysis. |
| Company Age | ~1 year | Early stage; financial history too short for trend analysis. |
3. Diagnosis
Liquidity and Solvency:
The company portrays "healthy cash flow" with cash reserves more than double its current liabilities, a vital sign of operational resilience. Positive net current assets suggest the company is not under immediate financial distress and can meet short-term obligations comfortably.
Capital Structure:
Shareholders’ funds are positive and entirely equity-based, implying no long-term debt burden. The company is well-capitalized for its size and early stage, which is a good "immune system" against financial shocks.
Profitability and Growth Potential:
No turnover or profit figures are disclosed in the accounts, likely due to the company’s early stage and the accounting exemption under small companies regime. This absence is a "symptom" indicating that the business might still be in investment or development phase, without yet generating significant revenue.
Governance and Control:
The sole director and majority shareholder, Mr Darren Robert Roulston, has full control, which simplifies decision-making but also concentrates risk. The company is compliant with filing deadlines and no overdue returns or accounts are reported, indicating good governance and compliance "vital signs."
4. Recommendations
Revenue Generation Focus: Accelerate efforts to generate turnover and establish profitability. The absence of revenue to date is a key area to monitor closely to avoid symptoms of stagnation.
Regular Cash Flow Monitoring: Maintain vigilant cash flow management to preserve liquidity. As current cash is healthy, ensure expenses do not outpace incoming funds as the business scales.
Build Financial Reporting: Consider preparing internal management accounts to track performance more granularly beyond statutory filings, enabling earlier detection of financial "symptoms" such as margin pressure or rising costs.
Diversify Governance Inputs: While single control simplifies operations, consider advisory support or non-executive directors to provide strategic oversight and reduce concentration risk.
Plan for Capital Needs: As the company grows, evaluate whether additional capital injections or financing will be needed to fund expansion or cover operational costs, ensuring the "heart" of the business—the capital base—remains strong.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.